Showing 1 - 10 of 2,466
The level of cognitive distance determines how detailed objects, persons or events are mentally construed. The higher the level of cognitive distance between two individuals, the lower the level of detail in mental representation of each other. In product development, a detailed conception of...
Persistent link: https://www.econbiz.de/10011280013
To stay ahead of the competition, firms need to constantly adapt to the changing environment by identifying new opportunities and product innovations. The search for future discontinuities and trends using external knowledge sources enables firms to develop a foresight capability to proactively...
Persistent link: https://www.econbiz.de/10011487420
Co-development alliances are formed to create new capabilities (technologies, products, services, processes, etc.) that partner organizations need in order to reach their goals. They involve the combination of competencies, and other intangible assets. These alliances typically face a high level...
Persistent link: https://www.econbiz.de/10009742115
This paper examines the automation and sharing aspects of the competitive dynamics of the emerging automated mobility industry. It applies strategic management, technological innovation and forecasting frameworks to examine how the different categories of industry entrants position themselves...
Persistent link: https://www.econbiz.de/10012244520
Persistent link: https://www.econbiz.de/10011702705
Persistent link: https://www.econbiz.de/10012164261
In den letzten Jahren hat die Diskussion über strategische Corporate Social Responsibility (CSR) verstärkt die Innovationsfunktion der Unternehmen und ihre Rolle als Agenten der "free market innovation machine" in den Blick genommen. Aufbauend auf dem Theorieangebot der Ordonomik, zeigt dieser...
Persistent link: https://www.econbiz.de/10011758154
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D...
Persistent link: https://www.econbiz.de/10012219372
Persistent link: https://www.econbiz.de/10014318254